Auna S.A. (AUNA) – What Are Analysts Saying About This Stock?

Shares of Auna S.A. (NYSE:AUNA) have been given an average recommendation of “Hold” by the five brokerages that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, one has assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year target price among brokers that have covered the stock in the last year is $6.97.

Several equities analysts recently issued reports on AUNA shares. Weiss Ratings reissued a “sell (d)” rating on shares of Auna in a report on Monday, September 21st. Wall Street Zen upgraded Auna from a “buy” rating to a “strong-buy” rating in a report on Saturday.

Auna Stock Up 2.5%

NYSE AUNA opened at $5.16 on Friday. The company has a quick ratio of 1.00, a current ratio of 1.08 and a debt-to-equity ratio of 1.61. Auna has a 52 week low of $4.09 and a 52 week high of $6.30. The firm has a market capitalization of $381.52 million, a price-to-earnings ratio of 73.65 and a beta of 0.62. The company has a fifty day moving average of $5.21 and a two-hundred day moving average of $5.12.

Auna (NYSE:AUNA) last released its earnings results on Friday, August 14th. The company reported $0.15 EPS for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.11). Auna had a net margin of 0.44% and a return on equity of 12.88%. The business had revenue of $362.85 million for the quarter, compared to the consensus estimate of $357.39 million. On average, analysts predict that Auna will post 0.79 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Renaissance Technologies LLC grew its stake in Auna by 487.7% during the 1st quarter. Renaissance Technologies LLC now owns 668,457 shares of the company’s stock valued at $3,683,000 after purchasing an additional 554,707 shares during the last quarter. Lazard Asset Management LLC purchased a new position in shares of Auna in the first quarter worth about $557,000. Hsbc Holdings PLC purchased a new position in shares of Auna in the first quarter worth about $324,000. Arrowstreet Capital Limited Partnership acquired a new stake in shares of Auna during the first quarter worth about $316,000. Finally, Squarepoint Ops LLC acquired a new stake in shares of Auna during the second quarter worth about $149,000.

More Auna News

Here are the key news stories impacting Auna this week:

• Positive Sentiment: Auna reaffirmed its full-year 2026 revenue-growth guidance, supported by favorable third-quarter patient volumes and specialty-service trends. The company also cited signs of recovery in Mexico, which may help offset pressure elsewhere. Auna Announces Preliminary Update to Full-Year 2026 Outlook
• Positive Sentiment: The company said all conditions precedent have been fulfilled for construction of the Centro Ambulatorio Trecca in Peru under its public-private partnership with EsSalud. The milestone reduces execution uncertainty and advances a potentially important long-term growth project. Centro Ambulatorio Trecca Conditions Precedent
• Positive Sentiment: Auna’s analyst and investor day provided additional investor visibility into its strategy, operating trends and regional growth opportunities. Auna Analyst and Investor Day Transcript
• Neutral Sentiment: Analysts cited a consensus price target of $6.97, implying potential upside from the recent trading level, although target prices are estimates rather than guarantees. Auna Consensus Target Price
• Negative Sentiment: Auna lowered its 2026 EBITDA outlook because of contract-related pressure in Colombia. The reduction raises concerns about near-term profitability and margins even though revenue guidance was maintained. Auna Cuts 2026 EBITDA Outlook

About Auna

Auna SA is a Latin American healthcare company that provides integrated medical services through a network of hospitals, clinics, outpatient centers and specialized care facilities. Its operations include hospital care, ambulatory services, diagnostic testing, oncology treatment, preventive care and other medical specialties.

The company also offers healthcare plans and programs designed to provide access to medical services, including specialized oncology coverage. Auna’s business model combines healthcare financing and service delivery, allowing it to serve patients across different stages of care, from prevention and diagnosis to treatment and follow-up.

Auna is headquartered in Peru and serves markets in Latin America, including Peru, Colombia and Mexico.